Opening book details…
About this Medicine article
Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden by J. Lundkvist; Wilking; S. Holmberg; M. Lidgren; L. Jönsson is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- J. Lundkvist; Wilking; S. Holmberg; M. Lidgren; L. Jönsson
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
- Published
- 2006
- Language
- EN
- Field
- Medicine (Health Sciences)
More by J. Lundkvist; Wilking; S. Holmberg; M. Lidgren; L. Jönsson
Browse all works by J. Lundkvist; Wilking; S. Holmberg; M. Lidgren; L. Jönsson